Tomer Kariv

Insider Reports History

Location
Flemington, NJ
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tomer Kariv:

Company Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. Director, 10%+ Owner Common Stock 155,262 $2,241,983 $14.44 04 Jun 2025 Indirect
Keros Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 10,500 04 Jun 2025 Direct
Eloxx Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 2,859 30 Jan 2023 Direct

Insider Reports Filed by Tomer Kariv

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KROS Keros Therapeutics, Inc. 04 Jun 2025 0 $0 4/A Director, 10%+ Owner 11 Jun 2025, 07:45
KROS Keros Therapeutics, Inc. 30 May 2024 1 $0 4 Director, 10%+ Owner 03 Jun 2024, 16:15
KROS Keros Therapeutics, Inc. 06 Jun 2023 1 $0 4 Director, 10%+ Owner 08 Jun 2023, 16:45
/report/000110465923008599-kariv-tomer-2023-01-30 Eloxx Pharmaceuticals, Inc. 30 Jan 2023 1 $0 4 Director 31 Jan 2023, 15:08
KROS Keros Therapeutics, Inc. 29 Nov 2022 6 -$0.7176 4 Director, 10%+ Owner 30 Nov 2022, 15:38
/report/000110465922072176-kariv-tomer-2022-06-15 Eloxx Pharmaceuticals, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 08:24
KROS Keros Therapeutics, Inc. 01 Jun 2022 1 $0 4 Director, 10%+ Owner 03 Jun 2022, 16:27
KROS Keros Therapeutics, Inc. 01 Jun 2021 1 $0 4 Director, 10%+ Owner 03 Jun 2021, 17:31
/report/000141588921002612-kariv-tomer-2021-05-19 Eloxx Pharmaceuticals, Inc. 19 May 2021 1 $0 4 Director 20 May 2021, 16:10
/report/000110465921067333-kariv-tomer-2021-05-13 Eloxx Pharmaceuticals, Inc. 13 May 2021 4 +$7,999,999 4 Director 17 May 2021, 07:00
KROS Keros Therapeutics, Inc. 07 Apr 2020 0 $0 3/A Director, 10%+ Owner 30 Nov 2022, 15:34